Related Experiment Videos
Survivin expression in pituitary adenomas.
Ryszard Wasko1, Anna Jankowska, Joanna Waligorska-Stachura
1University of Medical Sciences in Ponzan, Department of Endocrinology, Metabolism and Internal Diseases, Poland. rwasko@amp.edu.pl
Neuro Endocrinology Letters
|July 2, 2005
Summary
Survivin, a protein linked to cancer, is actively expressed in all human pituitary adenomas studied. This finding suggests survivin expression may help predict pituitary tumor growth and patient prognosis.
Area of Science:
- Oncology
- Molecular Biology
- Endocrinology
Background:
- Survivin is highly expressed in various human tumors and is a potential therapeutic target.
- Survivin expression is developmentally regulated and cell cycle-dependent, inhibiting apoptosis in proliferating cells.
- Its role in pituitary tumors is not well-defined.
Purpose of the Study:
- To investigate survivin gene expression in different types of human pituitary adenomas.
- To determine if survivin expression is a common feature across various pituitary adenoma subtypes.
Main Methods:
- Analysis of tissue samples from 12 patients with pituitary adenomas (acromegaly, non-functioning tumors, prolactinoma).
- RNA extraction, cDNA synthesis, and amplification of the survivin gene fragment.
- Surgical tumor removal was the primary method of tissue acquisition.
Main Results:
- Survivin gene expression was detected in all twelve analyzed pituitary adenoma samples.
- This confirms survivin expression as a characteristic feature of human pituitary adenomas.
- The study found active survivin gene presence across all tested tumor types.
Conclusions:
- Survivin expression is a consistent finding in human pituitary adenomas.
- Estimating survivin expression levels could potentially aid in predicting tumor growth and patient prognosis.
- Further research into survivin's role in pituitary tumorigenesis is warranted.